Logo image
Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997–2007
Journal article   Peer reviewed

Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997–2007

Jennifer N Lind, Sarah C Tinker, Cheryl S Broussard, Jennita Reefhuis, Suzan L Carmichael, Margaret A Honein, Richard S Olney, Samantha E Parker, Martha M Werler and National Birth Defects Prevention Study
Pharmacoepidemiology and drug safety, Vol.22(7), pp.783-793
07/2013
DOI: 10.1002/pds.3448
PMCID: PMC4037128
PMID: 23620412
url
https://www.ncbi.nlm.nih.gov/pmc/articles/4037128View
Open Access

Abstract

ABSTRACT Purpose To investigate associations between maternal use of common medications and herbals during early pregnancy and risk for hypospadias in male infants. Methods We used data from the National Birth Defects Prevention Study, a multi‐site, population‐based, case–control study. We analyzed data from 1537 infants with second‐degree or third‐degree isolated hypospadias and 4314 live‐born male control infants without major birth defects, with estimated dates of delivery from 1997 to 2007. Exposure was reported use of prescription or over‐the‐counter medications or herbal products, from 1 month before to 4 months after conception. Adjusted odds ratios (aORs) and 95% confidence intervals (CIs) were estimated using multivariable logistic regression, adjusting for maternal age, race/ethnicity, education, pre‐pregnancy body mass index, previous live births, maternal subfertility, study site, and year. Results We assessed 64 medication and 24 herbal components. Maternal uses of most components were not associated with an increased risk of hypospadias. A new associations was observed for venlafaxine (aOR 2.4; 95%CI 1.0, 6.0) [Correction made here after initial online publication.]. The previously reported association for clomiphene citrate was confirmed (aOR 1.9; 95%CI 1.2, 3.0). Numbers were relatively small for exposure to other specific patterns of fertility agents, but elevated aORs were observed for the most common of them. Conclusions Overall, findings were reassuring that hypospadias is not associated with most medication components examined in this analysis. New associations will need to be confirmed in other studies. Increased risks for hypospadias associated with various fertility agents raise the possibility of confounding by underlying subfertility. Copyright © 2013 John Wiley & Sons, Ltd.
Pregnancy birth defects drug safety herbal hypospadias medication pharmacoepidemiology

Details

Metrics

Logo image